Ignite Creation Date:
2024-05-06 @ 8:18 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06331832
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2024-03-26
First Post:
2024-03-19
Brief Title:
Expanded Access of Imvotamab IGM-2323 in Patients With RR NHL
Sponsor:
IGM Biosciences Inc
Organization:
IGM Biosciences Inc
Organization Data
Organization:
IGM Biosciences Inc
Class:
INDUSTRY
Study ID:
2323-EAP
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
IGM Biosciences Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None